MPM Capital is a healthcare investment firm that focuses on early-stage ventures in the biotechnology, pharmaceuticals, and medical technology sectors. The company leverages its deep experience and network in the healthcare industry to identify and invest in promising life sciences companies, providing them with strategic guidance and capital to develop innovative therapies and technologies.

MPM Capital

MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.

Clinical Ink

23andMe

Repare Therapeutics

Acceleron Pharma

Athersys

Humanigen

Nevro

Rhythm Pharmaceuticals

Syndax Pharmaceuticals

TCR2

TriNetX

Verastem Oncology

Harpoon Therapeutics

Semma Therapeutics

ITeos Therapeutics

Cullinan Oncology

Dyne Therapeutics

Entrada Therapeutics

Epizyme

MPM BioImpact

Metric
Company Name	MPM Capital
Symbol
MSH ID	COM:MPMCAPITAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Investment Management
Country	US
Stage
Employee Count	53
Website	mpmcapital.com
LinkedIn	mpm-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MPMCAPITAL

MPM Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue